Author:
Tan Lunfang,Li Yun,Wang Zhufeng,Wang Zihui,Liu Shuyi,Lin Junfeng,Huang Jinhai,Liang Lina,Peng Kang,Gao Yi,Zheng Jinping
Abstract
Abstract
Purpose
The present study aimed to investigate the clinical characteristics and lung function impairment in young people diagnosed with chronic obstructive pulmonary disease (COPD).
Patients and methods
We retrospectively enrolled patients with COPD who underwent symptom assessment and comprehensive pulmonary function tests at the First Affiliated Hospital of Guangzhou Medical University between August 2017 and March 2022. The patients were categorized into two groups based on age: a young COPD group (aged 20–50 years) and an old COPD group (aged > 50 years).
Results
A total of 1282 patients with COPD were included in the study, with 76 young COPD patients and 1206 old COPD patients. Young COPD patients exhibited a higher likelihood of being asymptomatic, lower rates of smoking, and a lower smoking index compared to old COPD patients. Although young COPD patients had higher median post-bronchodilator forced expiratory volume in 1 s (post-BD FEV1) (1.4 vs.1.2 L, P = 0.019), diffusing capacity of the lung for carbon monoxide (DLCO) (7.2 vs. 4.6, P<0.001), and a lower median residual volume to total lung capacity ratio (RV/TLC) compared to their older counterparts, there were no differences observed in severity distribution by GOLD categories or the proportion of lung hyperinflation (RV/TLC%pred > 120%) between two groups. Surprisingly, the prevalence of reduced DLCO was found to be 71.1% in young COPD, although lower than in old COPD (85.2%).
Conclusion
Young COPD showed fewer respiratory symptoms, yet displayed a similar severity distribution by GOLD categories. Furthermore, a majority of them demonstrated lung hyperinflation and reduced DLCO. These results underscore the importance of a comprehensive assessment of lung function in young COPD patients.
Funder
the Supported by R&D Program of Guangzhou National Laboratory
Medical Scientific Research Foundation of Guangdong Province
Zhongnanshan Meical Foundation of Guangdong Province
R&D Programme of Guangzhou National Laboratory
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. (GOLD) GIfCOLD: global strategy for prevention, diagnosis and management of COPD. 2024 Reprot. 2024. https:www.//goldcopdorg/2024-gold-report/. Update 2024.
2. Wang C, Xu J, Yang L, Xu Y, Zhang X, Bai C, Kang J, Ran P, Shen H, Wen F, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–17. https://doi.org/10.1016/s0140-6736(18)30841-9/.
3. Jo YS, Kim KJ, Rhee CK, Yoo KH, Jung KS, Park YB. Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease. Respir Res. 2022;23(1):212. https://doi.org/10.1186/s12931-022-02144-0/.
4. (GOLD) 2022 GIfCOLD: Global strategy for prevention, diagnosis and management of COPD, Reprot. https://www.goldcopdorg/2022-goldreports-2/.
5. Wang Z, Li Y, Lin J, Huang J, Zhang Q, Wang F, Tan L, Liu S, Gao Y, Peng S, et al. Prevalence, risk factors, and mortality of COPD in young people in the USA: results from a population-based retrospective cohort. BMJ Open Respir Res. 2023;10(1). https://doi.org/10.1136/bmjresp-2022-001550/.